RARE (Ultragenyx Pharmaceutical Inc.) Expected Profit

Graphic logo of Ultragenyx Pharmaceutical (RARE)

Ultragenyx Pharmaceutical brings together leading geneticists developing life-saving therapies for rare pathologies. The expected profit margin illustrates the market reaction to this potential, where the indicator value is 0.01. The growth of Crysvita and a promising pipeline are driving a revaluation of the asset, although strict FDA oversight and a small patient population create certain financial pressure on the company.

RARE: Ultragenyx Corp Projected Future Earnings 11/05/2026 - 11/19/2026

Metric breakdowns and analytics for Ultragenyx Corp (RARE)

General company analysis:Ultragenyx Corp
Finished products of Ultragenyx Pharma

This indicator aggregates market expectations for future net income, neutralizing reporting time lags to provide a real-time assessment of the asset's fundamental value. The trend in the projected profit levels of Ultragenyx Pharmaceutical (RARE) reflects the company's sensitivity to geopolitical risks and biocomponent supply chain disruptions, allowing investors to anticipate the impact of logistical constraints on business capitalization through the lens of forecasted earnings.

Competitors of Ultragenyx Pharmaceutical

Expected Profit Tempus AI|Projected Future Earnings Qiagen|Projected Future Earnings IONS|Expected Profit RGEN (Repligen Corp.)|Avidity - Future Profit|CRSP (crisprtx.com) - Forward Earnings|WGS: Future Profit|Beam Therapeutics - Future Net Profit|SRPT: Projected Future Earnings|TWST (Twist Bio) - Expected Profit|TXG (10xgenomics.com) - Projected Future Earnings|Projected Future Earnings Intellia Therapeutics, Inc.|Projected Future Earnings STOK|Company Profit Forecast BioLife Solutions Inc|Expected Profit Wave Pharma WVE|Projected Future Earnings Maze Therapeutics Corp MAZE|SION - Expected Profit|Prime Medicine, Inc. (PRME) - Future Profit|TSHA (Taysha Gene Therapies, Inc.) - Future Profit|QURE - Company Profit Forecast|MGTX (MeiraGTx Holdings plc) - Projected Future Earnings|Future Profit REGENXBIO Inc. (RGNX)|Expected Profit Solid Biosciences (SLDB)|ocugen.com (OCGN) - Projected Net Profit|Projected Future Earnings PACB (PacBio Corp)|Expected Net Income BNTC|DSGN: Future Profit|RCKT - Projected Future Earnings|Expected Net Income 4D Molecular Corp FDMT|Future Profit Lexeo|Expected Profit Korro Bio Inc.|Net Profit Forecast EDIT (Editas Medicine)|Expected Profit Silence Therapeutics Corp (SLN)|PRQR (ProQR) - Expected Net Income|Projected Future Earnings CDXS (Codexis, Inc.)|Company Profit Forecast sangamo.com (SGMO)|nautilus.bio - Projected Future Earnings|Metagenomi (MGX) - Future Profit|DTIL: Projected Future Earnings|Expected Net Profit Generation Bio Co (GBIO)|BOLD (Boundless Bio) - Projected Future Earnings|Future Profit Exicure (XCUR)|Expected Profit Celsion Corporation (IMNN)|PHIO - Expected Net Profit|Mustang Bio Inc - Future Profit|Projected Future Earnings transcodetherapeutics.com RNAZ|Bionano Genomics Inc. - Projected Future Earnings|APDN (Applied DNA Sciences) - Net Profit Forecast|BLUE (bluebirdbio.com) - Future Profit|Net Profit Forecast IPA|OMGA (omegatherapeutics.com) - Projected Future Earnings|Singular Genomics Systems Inc (OMIC) - Company Profit Forecast|Projected Future Earnings RGLS|Company Profit Forecast Syros Pharmaceuticals, Inc.|Expected Profit Telesis Bio Inc. TBIO|Future Net Profit TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Projected Future Earnings